Mr. Christian Dewolf Weeks, LMHC Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 231 Bonnet St # 4, Manchester Center, VT 05255 Phone: 401-617-2737 |
Emma Wood, MS, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 4697 Main St, Manchester Center, VT 05255 Phone: 802-768-1289 |
News Archive
Democratic leaders are terming this week's Senate vote on the House-passed Ryan budget, including its proposal to revamp Medicare, a "defining issue." Meanwhile, some Republican senators have announced that they won't back the plan.
"On one proposal for health care reform at least, there is a rare bipartisan consensus: the push to computerize patient records," The New York Times reports. The federal recovery package sets aside $19 billion "to encourage doctors and hospitals to install and use electronic health records. So even as the Obama administration and Congress struggle with broad health policy legislation, the technology industry is pursuing the opportunity in digital health records as never before." The money will not be available until next year, but General Electric, I.B.M. and Verizon are all "hoping to get their share."
The Barbara Ann Karmanos Cancer Institute, in partnership with Wayne State University School of Medicine, is one of the lead academic centers participating in the National Cancer Institute's (NCI) MATCH (Molecular Analysis for Therapy Choice) Trial in the United States, set to begin in the next few weeks.
Antidepressant medications taken by pregnant women are associated with increased rates of preterm birth. This finding reinforces the notion that antidepressants should not be used by pregnant women in the absence of a clear need that cannot be met through alternative approaches, say researchers from Brigham and Women's Hospital, Vanderbilt University, MetroWest Medical Center, and Tufts Medical Center.
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the European Patent Office intends to grant a patent for application EP06826368 covering formulations for the intranasal delivery of rapid acting insulin, and its use for the treatment of diabetes.
› Verified 4 days ago